Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Noninvasive detection of Alzheimer's disease (AD) with high specificity and sensitivity can greatly facilitate identification of at-risk populations for earlier, more effective intervention. AD patients exhibit a myriad of retinal pathologies, including hallmark amyloid β-protein (Aβ) deposits. METHODS: Burden, distribution, cellular layer, and structure of retinal Aβ plaques were analyzed in flat mounts and cross sections of definite AD patients and controls (n = 37). In a proof-of-concept retinal imaging trial (n = 16), amyloid probe curcumin formulation was determined and protocol was established for retinal amyloid imaging in live patients. RESULTS: Histological examination uncovered classical and neuritic-like Aβ deposits with increased retinal Aβ42 plaques (4.7-fold; P = 0.0063) and neuronal loss (P = 0.0023) in AD patients versus matched controls. Retinal Aβ plaque mirrored brain pathology, especially in the primary visual cortex (P = 0.0097 to P = 0.0018; Pearson's r = 0.84-0.91). Retinal deposits often associated with blood vessels and occurred in hot spot peripheral regions of the superior quadrant and innermost retinal layers. Transmission electron microscopy revealed retinal Aβ assembled into protofibrils and fibrils. Moreover, the ability to image retinal amyloid deposits with solid-lipid curcumin and a modified scanning laser ophthalmoscope was demonstrated in live patients. A fully automated calculation of the retinal amyloid index (RAI), a quantitative measure of increased curcumin fluorescence, was constructed. Analysis of RAI scores showed a 2.1-fold increase in AD patients versus controls (P = 0.0031). CONCLUSION: The geometric distribution and increased burden of retinal amyloid pathology in AD, together with the feasibility to noninvasively detect discrete retinal amyloid deposits in living patients, may lead to a practical approach for large-scale AD diagnosis and monitoring. FUNDING: National Institute on Aging award (AG044897) and The Saban and The Marciano Family Foundations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,039
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Self-citationNeurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0024 · Cited by 1,331
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils
Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., & Smith, S. O. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1799 · Cited by 1,111
Cerebral amyloid angiopathy. A critical review.
Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,071
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Glia–neuron interactions in the mammalian retina
Vecino, E., Rodriguez, F. D., Ruzafa, N., Pereiro, X., & Sharma, S. C. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.06.003 · Cited by 825
Patton, N., Aslam, T., MacGillivray, T., Pattie, A., Deary, I. J., & Dhillon, B. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00395.x · Cited by 807
Al-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765
Sleep Quality and Preclinical Alzheimer Disease
Ju, Y.-E. S., McLeland, J. S., Toedebusch, C. D., Xiong, C., Fagan, A. M., Duntley, S. P., Morris, J. C., & Holtzman, D. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2334 · Cited by 744 · cited 2×
“possibly explain sleep disturbances seen in these patients (44).”
BackgroundCerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study
Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
Perrin, R. J., Fagan, A. M., & Holtzman, D. M. (2009) · Nature · doi:10.1038/nature08538 · Cited by 702 · cited 1×
“Structural conversion of neurotoxic amyloid-beta (1-42) oligomers to fibrils.”
BackgroundOptic-Nerve Degeneration in Alzheimer's Disease
Hinton, D. R., Sadun, A. A., Blanks, J. C., & Miller, C. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608213150804 · Cited by 694
Self-citationReduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue
Schnell, S. A., Staines, W. A., & Wessendorf, M. W. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700601 · Cited by 688
Koronyo-Hamaoui, M., Koronyo, Y., Ljubimov, A. V., Miller, C. A., Ko, M. K., Black, K. L., Schwartz, M., & Farkas, D. L. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.020 · Cited by 672
Self-citationGarcia‐Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T., & Bacskai, B. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04613.x · Cited by 661
Begum, A. N., Jones, M. R., Lim, G. P., Morihara, T., Kim, P., Heath, D. D., Rock, C. L., Pruitt, M. A., Yang, F., Hudspeth, B., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137455 · Cited by 604 · cited 1×
“Plasma and RBC samples were analyzed by LCMSMS as previously described (113).”
MethodSelf-citationRetinal Abnormalities in Early Alzheimer’s Disease
Berisha, F., Feke, G. T., Trempe, C. L., McMeel, J. W., & Schepens, C. L. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-1029 · Cited by 504
Amyloid biomarkers in Alzheimer's disease
Blennow, K., Mattsson, N., Schöll, M., Hansson, O., & Zetterberg, H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.002 · Cited by 470 · cited 2×
“Existing brain amyloid–imaging tools are invaluable for research and diagnosis (7), yet they present challenges for screening large-scale populations in clinical settings and predicting disease progression (8, 9).”
BackgroundJohnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., & Anderson, D. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192203399 · Cited by 447
Brain β-amyloid load approaches a plateau
Jack, C. R., Wiste, H. J., Lesnick, T. G., Weigand, S. D., Knopman, D. S., Vemuri, P., Pankratz, V. S., Senjem, M. L., Gunter, J. L., Mielke, M. M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840bbe · Cited by 406
Melanopsin retinal ganglion cell loss in Alzheimer disease
La Morgia, C., Ross‐Cisneros, F. N., Koronyo, Y., Hannibal, J., Gallassi, R., Cantalupo, G., Sambati, L., Pan, B. X., Tozer, K. R., Barboni, P., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24548 · Cited by 390
Self-citationCox, K. H., Pipingas, A., & Scholey, A. B. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114552744 · Cited by 368
Goldstein, L. E., Muffat, J. A., Cherny, R. A., Moir, R. D., Ericsson, M. H., Huang, X., Mavros, C., Coccia, J. A., Faget, K. Y., Fitch, K. A., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12981-9 · Cited by 363
Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease
Paquet, C., Boissonnot, M., Roger, F., Dighiero, P., Gil, R., & Hugon, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.090 · Cited by 353
Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau
Hardy, J., Duff, K., Hardy, K. G., Perez-Tur, J., & Hutton, M. (1998) · Nature Neuroscience · doi:10.1038/1565 · Cited by 347
Retinal ganglion cells in Alzheimer's disease and aging
Curcio, C. A., & Drucker, D. N. (1993) · Annals of Neurology · doi:10.1002/ana.410330305 · Cited by 308
Amyloid-β Deposits Lead to Retinal Degeneration in a Mouse Model of Alzheimer Disease
Ning, A., Cui, J., To, E., Ashe, K. H., & Matsubara, J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1849 · Cited by 303
Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease
Kesler, A., Vakhapova, V., Korczyn, A. D., Naftaliev, E., & Neudorfer, M. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.02.014 · Cited by 298
Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease
Frost, S., Kanagasingam, Y., Sohrabi, H., Vignarajan, J., Bourgeat, P., Salvado, O., Villemagne, V, Rowe, C. C., Lance Macaulay, S., Szoeke, C., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.150 · Cited by 297
Retinal ganglion cell degeneration in Alzheimer's disease
Blanks, J. C., Hinton, D. R., Sadun, A. A., & Miller, C. A. (1989) · Brain Research · doi:10.1016/0006-8993(89)90653-7 · Cited by 297
Self-citationRetinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL
Blanks, J. C., Schmidt, S. Y., Torigoe, Y., Porrello, K. V., Hinton, D. R., & Blanks, R. H. I. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00009-7 · Cited by 287
Self-citationClearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes
Zuroff, L., Daley, D., Black, K. L., & Koronyo-Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 275
Self-citationGota, V. S., Maru, G. B., Soni, T. G., Gandhi, T. R., Kochar, N., & Agarwal, M. G. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9024807 · Cited by 274
Ocular indicators of Alzheimer’s: exploring disease in the retina
Hart, N. J., Koronyo, Y., Black, K. L., & Koronyo-Hamaoui, M. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1613-6 · Cited by 261
Self-citationDentchev, T., Milam, A. H., Lee, V. M. ‐., Trojanowski, J. Q., & Dunaief, J. L. (2003) · PubMed · Cited by 252
Lu, Y., Li, Z., Zhang, X., Ming, B., Jia, J., Wang, R., & Ma, D. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.006 · Cited by 248
Brain and Retinal Pericytes: Origin, Function and Role
Trost, A., Lange, S., Schroedl, F., Bruckner, D., Motloch, K. A., Bogner, B., Kaser-Eichberger, A., Strohmaier, C., Runge, C., Aigner, L., et al. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00020 · Cited by 244 · cited 1×
“Structural conversion of neurotoxic amyloid-beta (1-42) oligomers to fibrils.”
BackgroundDiverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people
DiSilvestro, R. A., Joseph, E., Zhao, S., & Bomser, J. (2012) · Nutrition Journal · doi:10.1186/1475-2891-11-79 · Cited by 243
Perez, S. E., Lumayag, S., Kovacs, B., Mufson, E. J., & Xu, S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2384 · Cited by 230
Retinal Nerve Fiber Layer Thickness in Patients With Alzheimer Disease
Kirbas, S., Turkyilmaz, K., Anlar, O., Tufekci, A., & Durmus, M. (2013) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e318267fd5f · Cited by 217
Marziani, E., Pomati, S., Ramolfo, P., Cigada, M., Giani, A., Mariani, C., & Staurenghi, G. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12046 · Cited by 215
Optical Coherence Tomography in Alzheimer’s Disease: A Meta-Analysis
Coppola, G., Di Renzo, A., Ziccardi, L., Martelli, F., Fadda, A., Manni, G., Barboni, P., Pierelli, F., Sadun, A. A., & Parisi, V. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134750 · Cited by 205
Ryu, E. K., Choe, Y. S., Lee, K.-H., Choi, Y., & Kim, B.-T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0607193 · Cited by 198
Katz, B., Rimmer, S., Iragui, V., & Katzman, R. (1989) · Annals of Neurology · doi:10.1002/ana.410260207 · Cited by 198
Koronyo, Y., Salumbides, B. C., Black, K. L., & Koronyo-Hamaoui, M. (2012) · Neurodegenerative Diseases · doi:10.1159/000335154 · Cited by 196
Self-citationα‐synuclein in the inner retina in parkinson disease
Bodis‐Wollner, I., Kozlowski, P. B., Glazman, S., & Miri, S. (2014) · Annals of Neurology · doi:10.1002/ana.24182 · Cited by 192 · cited 1×
“Therefore, while Ho and colleagues (43) were unable to detect Aβ, p-tau, or α-synuclein in any ocular tissue of AD or Parkinson’s disease (PD) patients, considerably more independent studies in fact reported the presence of Aβ deposits in the retina and lenses (11, 39, 40, 42, 51, 83) as well as identified p-tau (41)…”
BackgroundLong-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice
Schön, C., Hoffmann, N. A., Ochs, S. M., Burgold, S., Filser, S., Steinbach, S., Seeliger, M. W., Arzberger, T., Goedert, M., Kretzschmar, H. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053547 · Cited by 192
Liu, B., Rasool, S., Yang, Z., Glabe, C. G., Schreiber, S. S., Ge, J., & Tan, Z. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090159 · Cited by 182
Moreno-Ramos, T., Benito-León, J., Villarejo, A., & Bermejo-Pareja, F. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-121975 · Cited by 181
Frautschy, S. A., Cole, G. M., & Baird, A. (1992) · PubMed Central · Cited by 177
Self-citationGao, L., Liu, Y., Li, X., Bai, Q., & Liu, P. (2014) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2014.10.011 · Cited by 173
Visual field loss in senile dementia of the Alzheimer's type
Trick, G. L., Trick, L. R., Morris, P., & Wolf, M. (1995) · Neurology · doi:10.1212/wnl.45.1.68 · Cited by 166
Yanagisawa, D., Shirai, N., Amatsubo, T., Taguchi, H., Hirao, K., Urushitani, M., Morikawa, S., Inubushi, T., Kato, M. G., Kato, F., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.142 · Cited by 165
Ho, C., Troncoso, J. C., Knox, D., Stark, W., & Eberhart, C. G. (2014) · Brain Pathology · doi:10.1111/bpa.12070 · Cited by 159
Risacher, S. L., WuDunn, D., Pepin, S. M., MaGee, T. R., McDonald, B. C., Flashman, L. A., Wishart, H. A., Pixley, H. S., Rabin, L. A., Paré, N., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.007 · Cited by 158
Alzheimers Disease and Retinal Neurodegeneration
Guo, L., Duggan, J., & Cordeiro, M. (2010) · Current Alzheimer Research · doi:10.2174/156720510790274491 · Cited by 158
Abnormal pattern electroretinograms in patients with senile dementia of the alzheimer type
Trick, G. L., Barris, M. C., & Bickler‐Bluth, M. (1989) · Annals of Neurology · doi:10.1002/ana.410260208 · Cited by 155
Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer’s disease
Dutescu, R. M., Li, Q., Crowston, J. G., Masters, C. L., Baird, P. N., & Culvenor, J. G. (2009) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1060-3 · Cited by 155
Dementia of the eye: the role of amyloid beta in retinal degeneration
Ratnayaka, J. A., Serpell, L. C., & Lotery, A. J. (2015) · Eye · doi:10.1038/eye.2015.100 · Cited by 153
Ocular changes in TgF344-AD rat model of Alzheimer's disease
Tsai, Y., Lu, B., Ljubimov, A. V., Girman, S., Ross-Cisneros, F. N., Sadun, A. A., Svendsen, C. N., Cohen, R. M., & Wang, S. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12888 · Cited by 153
Retinal microvascular network attenuation in Alzheimer's disease
Williams, M. A., McGowan, A. J., Cardwell, C. R., Cheung, C. Y., Craig, D., Passmore, P., Silvestri, G., Maxwell, A. P., & McKay, G. J. (2015) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.04.001 · Cited by 152
Retinal blood flow in mild cognitive impairment and Alzheimer's disease
Feke, G. T., Hyman, B. T., Stern, R. A., & Pasquale, L. R. (2015) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.01.004 · Cited by 151
Bayhan, H. A., Bayhan, S. A., Çelikbilek, A., Tanık, N., & Gürdal, C. (2014) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12386 · Cited by 147
Bieschke, J., Zhang, Q., Powers, E. T., Lerner, R. A., & Kelly, J. W. (2005) · Biochemistry · doi:10.1021/bi0501030 · Cited by 144
Motion Perception and Alzheimer's Disease
Gilmore, G. C., Wenk, H. E., Naylor, L. A., & Koss, E. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.p52 · Cited by 142
Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer’s disease
Kimbrough, I. F., Robel, S., Roberson, E. D., & Sontheimer, H. (2015) · Brain · doi:10.1093/brain/awv327 · Cited by 137
Cai, J., Qi, X., Kociok, N., Skosyrski, S., Emilio, A., Ruan, Q., Han, S., Liu, L., Chen, Z., Bowes Rickman, C., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101084 · Cited by 136 · cited 1×
“Structural conversion of neurotoxic amyloid-beta (1-42) oligomers to fibrils.”
BackgroundMore, S. S., & Vince, R. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500242z · Cited by 131
Structural and Functional Impairment of the Retina and Optic Nerve in Alzheimer’s Disease
M Moschos, M., Markopoulos, I., Chatziralli, I., Rouvas, A., G Papageorgiou, S., Ladas, I., & Vassilopoulos, D. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455340 · Cited by 129
Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease
Alexandrov, P. N., Pogue, A., Bhattacharjee, S., & Lukiw, W. J. (2011) · Neuroreport · doi:10.1097/wnr.0b013e3283497334 · Cited by 128 · cited 4×
“Therefore, while Ho and colleagues (43) were unable to detect Aβ, p-tau, or α-synuclein in any ocular tissue of AD or Parkinson’s disease (PD) patients, considerably more independent studies in fact reported the presence of Aβ deposits in the retina and lenses (11, 39, 40, 42, 51, 83) as well as identified p-tau (41)…”
BackgroundResultInfluentialGupta, V., Chitranshi, N., Gupta, V. B., Golzan, M., Dheer, Y., Wall, R. V., Georgevsky, D., King, A. E., Vickers, J. C., Chung, R. S., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.059 · Cited by 128
Curcumin Binding to Beta Amyloid: A Computational Study
Rao, P. P. N., Mohamed, T., Teckwani, K. N., & Tin, G. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12552 · Cited by 127
Detection of Retinal Nerve Fiber Layer Defects in Alzheimer’s Disease Using SD-OCT
Kromer, R., Serbecic, N., Hausner, L., Froelich, L., Aboul‐Enein, F., & Beutelspacher, S. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00022 · Cited by 121
Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques
Pensalfini, A., Albay, R., Rasool, S., Wu, J. W., Hatami, A., Arai, H., Margol, L., Milton, S., Poon, W. W., Corrada, M. M., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.011 · Cited by 120 · cited 1×
“Recent studies have demonstrated the detrimental effects of intracellular Aβ, by way of oligomerization into pathological forms within the endoplasmic reticulum (88), as well as the formation of neuritic plaques from degenerating neurons containing intracellular Aβ (89).”
BackgroundRetinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease
Williams, P. A., Thirgood, R. A., Oliphant, H., Frizzati, A., Littlewood, E., Votruba, M., Good, M. A., Williams, J. H., & Morgan, J. E. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.006 · Cited by 114
Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo
Cordeiro, M. F., Guo, L., Coxon, K. M., Duggan, J., Nizari, S., Normando, E. M., Sensi, S. L., Sillito, A. M., Fitzke, F. W., Salt, T. E., et al. (2010) · Cell Death & Disease · doi:10.1038/cddis.2009.3 · Cited by 113
Ocular Biomarkers for Early Detection of Alzheimer's Disease
Frost, S., Martins, R. N., & Kanagasingam, Y. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100819 · Cited by 106
Solid-state NMR analysis of interaction sites of curcumin and 42-residue amyloid β-protein fibrils
Masuda, Y., Fukuchi, M., Yatagawa, T., Tada, M., Takeda, K., Irie, K., Akagi, K., Monobe, Y., Imazawa, T., & Takegoshi, K. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.08.052 · Cited by 101
Dadhaniya, P., Patel, C. D., Muchhara, J., Bhadja, N. D., Mathuria, N., Vachhani, K., & Soni, M. G. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.05.001 · Cited by 91
Individual estimates of age at detectable amyloid onset for risk factor assessment
Bilgel, M., An, Y., Zhou, Y., Wong, D. F., Prince, J. L., Ferrucci, L., & Resnick, S. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.08.166 · Cited by 91
Curcuminoid Binds to Amyloid-β1-42 Oligomer and Fibril
Yanagisawa, D., Taguchi, H., Yamamoto, A., Shirai, N., Hirao, K., & Tooyama, I. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-102100 · Cited by 85
β-Amyloid Plaques: Stages in Life History or Independent Origin?
Armstrong, R. A. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017051 · Cited by 84
Morin, P. J., Abraham, C. R., Amaratunga, A., Johnson, R. J., Huber, G., Sandell, J. H., & Fine, R. E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb02147.x · Cited by 83
Maiti, P., Hall, T. C., Paladugu, L., Kolli, N., Learman, C. R., Rossignol, J., & Dunbar, G. L. (2016) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1464-1 · Cited by 83
Greater Attenuation of Retinal Nerve Fiber Layer Thickness in Alzheimer's Disease Patients
Shi, Z., Wu, Y., Wang, M., Cao, J., Feng, W. G., Cheng, Y., Li, C., & Shen, Y. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131898 · Cited by 81
Intracellular amyloid beta alters the tight junction of retinal pigment epithelium in 5XFAD mice
Park, S. W., Kim, J. H., Mook‐Jung, I., Kim, K.-W., Park, W. J., Park, K. H., & Kim, J. H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.008 · Cited by 81
Vertebrate retina and hypothalamus development
Byerly, M. S., & Blackshaw, S. (2009) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.22 · Cited by 76
Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease
Edwards, M. M., Rodriguez, J. J., Gutiérrez-Lanza, R., Yates, J., Verkhratsky, A., & Lutty, G. A. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.08.006 · Cited by 74
MUTSUGA, M., CHAMBERS, J. K., UCHIDA, K., TEI, M., MAKIBUCHI, T., MIZOROGI, T., TAKASHIMA, A., & NAKAYAMA, H. (2012) · Journal of Veterinary Medical Science · doi:10.1292/jvms.11-0307 · Cited by 70
Khan, T. K., & Alkon, D. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150238 · Cited by 67
On the subject of rigor in the study of amyloid β-protein assembly
Teplow, D. B. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt203 · Cited by 61
Mechanistic Insights of Curcumin Interactions with the Core-Recognition Motif of β-Amyloid Peptide
Kumaraswamy, P., Sethuraman, S., & Krishnan, U. M. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4000709 · Cited by 60
Gao, L., Chen, X., Tang, Y., Zhao, J., Li, Q., Fan, X., Xu, H., & Yin, Z. Q. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.04.013 · Cited by 58
Zhao, H., Chang, R., Che, H., Wang, J., Yang, L., Wei, F., Xia, Y., Li, N., Ma, Q., & Wang, X. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.026 · Cited by 55
Alzheimer’s Disease-Related Protein Expression in the Retina of Octodon degus
Du, L. Y., Chang, L., Ardiles, Á. O., Tapia‐Rojas, C., Araya, J., Inestrosa, N. C., Palacios, A. G., & Acosta, M. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135499 · Cited by 54
Meli, G., Lecci, A., Manca, A., Jakovljevic, N. K., Albertini, V., Benussi, L., Ghidoni, R., & Cattaneo, A. (2014) · Nature Communications · doi:10.1038/ncomms4867 · Cited by 54
Drusen maculopathy: a risk factor for visual deterioration
Algvere, P. V., Kvanta, A., & Seregard, S. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13011 · Cited by 50
Age-related structural abnormalities in the human
Han, M., Giese, G., Schmitz-Valckenberg, S., Bindewald-Wittich, A., Holz, F. G., Yu, J., Bille, J. F., & Niemz, M. H. (2007) · Journal of Biomedical Optics · doi:10.1117/1.2717522 · Cited by 49
Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin
Parthasarathy, R., Chow, K. M., Derafshi, Z., Fautsch, M. P., Hetling, J. R., Rodgers, D. W., Hersh, L. B., & Pepperberg, D. R. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.06.027 · Cited by 47
Kobayashi, S., Tateno, M., Utsumi, K., Takahashi, A., Saitoh, M., Morii, H., Fujii, K., & Teraoka, M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.07.015 · Cited by 44
Progressive inflammatory pathology in the retina of aluminum-fed 5xFAD transgenic mice
Pogue, A. I., Dua, P., Hill, J. M., & Lukiw, W. J. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.07.009 · Cited by 41
Retinal examination for the diagnosis of Alzheimer's disease
Kayabasi, U. (2014) · International Journal of Ophthalmic & Pathology · doi:10.4172/2324-8599.1000145 · Cited by 34
Yang, Y. J., Shiao, C., Hemingway, J. F., Jorstad, N. L., Shalloway, B. R., Chang, R. C., & Keene, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064246 · Cited by 31
Wang, H., Huang, J.-F., Li, L., Luo, J., Chen, D., Tong, J., Zeng, L., Cao, Y.-Q., Xiang, J., Luo, X.-G., et al. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.179057 · Cited by 27
He, Y., Zhao, H., & Su, G. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0173-7 · Cited by 23
Compounds for imaging amyloid-β deposits in an Alzheimer’s brain: a patent review
Tu, P., Fu, H., & Cui, M. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1007953 · Cited by 20
Cited by
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Spectral-Domain OCT Measurements in Alzheimer’s Disease
Chan, V. T. T., Sun, Z., Tang, S., Chen, L. J., Wong, A., Tham, C. C., Wong, T. Y., Chen, C., Ikram, M. K., Whitson, H. E., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.08.009 · Cited by 360
Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies
Curcio, C. A. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.18-24882 · Cited by 318
Aducanumab: Appropriate Use Recommendations
Cummings, J., Aisen, P., Apostolova, L. G., Atri, A., Salloway, S., & Weiner, M. (2021) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2021.41 · Cited by 316
“Amyloid is deposited in the retina in AD, and retinal imaging might be another means of detecting central nervous system amyloidosis (82, 83).”
Hadoux, X., Hui, F., Lim, J. K. H., Masters, C. L., Pébay, A., Chevalier, S., Ha, J., Loi, S., Fowler, C. J., Rowe, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12242-1 · Cited by 304
Metadata
- Authors
- Koronyo, Y., Biggs, D., Barron, E., Boyer, D. S., Pearlman, J. A., Au, W. J., Kile, S. J., Blanco, A., Fuchs, D.-T., Ashfaq, A., Frautschy, S., Cole, G. M., Miller, C. A., Hinton, D. R., Verdooner, S. R., Black, K. L., & Koronyo-Hamaoui, M.
- Venue
- JCI Insight
- Published
- 2017-08-17
- Volume
- 2
- Issue
- 16
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W2750510345
- Cited by
- 510
- References
- 114
- FWCI
- 27.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.